DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 1 USDMF, 3 Listed Suppliers

4 API Suppliers
1 USDMF
3 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 1 FDA Orange Book, 1 Europe, 1 Canada

3 FDF Dossiers
1 FDA Orange Book
1 Europe
1 Canada

GLOBAL SALES INFORMATION

4 Annual Reports

globalSalesInformation
4 Annual Reports

MARKET PLACE

1 APIs, 2 FDF Dossiers

marketPlace
1 APIs
2 FDF Dossiers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

728

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 9002-12-4, Azane;[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl [5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate, Oxidase, urate, Uricase, candida utilis, Mfcd00082126, Ft-0686693

Molecular Formula

C₁₈H₂₆N₅O₁₄P

Molecular Weight

567.4 g/mol

InChI Key

VPXDHZMLJOJKOX-UHFFFAOYSA-N

An enzyme that catalyzes the conversion of urate and unidentified products. It is a copper protein. The initial products decompose to form allantoin. EC 1.7.3.3.

1 2D Structure

Urate Oxidase

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

azane;[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl [5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate

2.1.2 InChI

InChI=1S/C18H23N4O14P.H3N/c23-5-7-14(13(28)16(34-7)22-4-2-10(25)20-18(22)30)36-37(31,32)33-6-8-11(26)12(27)15(35-8)21-3-1-9(24)19-17(21)29;/h1-4,7-8,11-16,23,26-28H,5-6H2,(H,31,32)(H,19,24,29)(H,20,25,30);1H3

2.1.3 InChI Key

VPXDHZMLJOJKOX-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OC3C(OC(C3O)N4C=CC(=O)NC4=O)CO)O)O.N

2.2 Synonyms

2.2.1 MeSH Synonyms

1. Oxidase, Urate

2. Urate Oxidase

3. Uricase

2.2.2 Depositor-Supplied Synonyms

1. 9002-12-4

2. Azane;[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl [5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] Hydrogen Phosphate

3. Oxidase, Urate

4. Uricase, Candida Utilis

5. Mfcd00082126

6. Ft-0686693

7. Ft-0772402

8. Uricase From Bacillus Fastidiosus, Lyophilized, ~9 U/mg

9. Uricase From Arthrobacter Globiformis, Lyophilized Powder, 15-30 Units/mg Protein (biuret)

10. Uricase From Candida Sp., Recombinant, Expressed In E. Coli, Lyophilized Powder, >=2 Units/mg Solid

2.3 Create Date

2007-02-09

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₂₆N₅O₁₄P
Molecular Weight	567.4 g/mol
Hydrogen Bond Donor Count	8
Hydrogen Bond Acceptor Count	15
Rotatable Bond Count	8
Exact Mass	567.12138752 g/mol
Monoisotopic Mass	567.12138752 g/mol
Topological Polar Surface Area	255 Å²
Heavy Atom Count	38
Formal Charge	0
Complexity	1070
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	8
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2